RESUMEN
A comprehensive phylogenetic study based on the hemagglutinin (H) protein of all known African measles virus (MV) isolates is presented. The study includes 64 new H gene sequences from Ghana. Nigeria and South Africa as well as viruses from Zambia and The Gambia for which only incomplete sequencing data were available and that have previously not been genotyped. The results provide further support to the tentative assignment of the Nigerian and Ghanaian viruses to a new genotype B3 within clade B. A distinct geographic distribution pattern emerged with clade B viruses circulating exclusively in African countries north of the equator. All MV strains from southern Africa grouped in clades A and D with the majority of viruses belonging to genotype D4. The viruses considerably differed by their sensitivity to neutralization by monoclonal antibodies (mAb), but three selected antibodies were sufficient to distinguish between African MVs representing four different genotypes.
Asunto(s)
Antígenos Virales/genética , Hemaglutininas Virales/genética , Virus del Sarampión/genética , África , Antígenos Virales/clasificación , Antígenos Virales/inmunología , Secuencia de Bases , Línea Celular , ADN Viral , Genotipo , Hemaglutininas Virales/clasificación , Hemaglutininas Virales/inmunología , Humanos , Virus del Sarampión/inmunología , Virus del Sarampión/aislamiento & purificación , Datos de Secuencia MolecularRESUMEN
A total of 635 clinically diagnosed typhoid fever patients were bled from three different health institutions in the metropolis of Lagos, Nigeria over a period of 15 months, May 1997 to July 1998. Out of the total blood cultured, 101 (15.9%) isolates of Salmonella species were isolated of which 68 (67.3%) were S. typhi, 17 (16.8%) and 16 (15.8%) were S. paratyphi A. and S. arizonae respectively. The overall isolation rate of S. typhi among patients is 10.7%, with most isolates 45.9% found among the severely-ill young adults, age group 16-30 years. All isolates were subjected to anti-microbial susceptibility testing using 12 different antibiotics: chloramphenicol, ampicillin, cotrimoxazole, gentamicin, colistin sulfate, nalidixic acid, nitrofurantoin, cefotaxime, tetracycline, streptomycin, ofloxacin and ciprofloxacin. All the S. typhi and S. paratyphi A isolates showed resistance to two or more of the 10 of 12 antibiotics tested particularly the 3-first-line antibiotics commonly used (chloramphenicol, ampicillin and cotrimoxazole) in the treatment of typhoid fever in Nigeria. No isolate showed resistance to ofloxacin and ciprofloxacin, however, nalidixic acid and gentamicin showed a moderate and appreciable inhibition to most of our isolates.
Asunto(s)
Antibacterianos/farmacología , Resistencia a Múltiples Medicamentos , Salmonella typhi/efectos de los fármacos , Fiebre Tifoidea/microbiología , Adolescente , Adulto , Niño , Preescolar , Femenino , Humanos , Lactante , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Nigeria , Salmonella arizonae/efectos de los fármacos , Salmonella arizonae/aislamiento & purificación , Salmonella paratyphi A/efectos de los fármacos , Salmonella paratyphi A/aislamiento & purificación , Salmonella typhi/genética , Salmonella typhi/aislamiento & purificación , Fiebre Tifoidea/sangre , Fiebre Tifoidea/tratamiento farmacológicoRESUMEN
Over a period of 12 months, a total of 852 stool samples from patients (both children and adults) with acute diarrhoeal diseases attending some public and government recognised health institutions in Lagos metropolis were screened for diarrhoeagenic bacterial agents. One hundred and eighty two bacterial isolates were found out of which 83 (45.6%) were Escherichia coli, 38 (20.9%) Shigella spp, 31 (17%) Salmonella spp, 16 (8.8%) Klebsiella spp, eight (4.4%) Aeromonas spp, while there were only six (3.3%) isolates for Plesiomonas spp. Of the 83 isolates for E. coli group, 49 (59%) were enteropathogenic (EPEC), 17 (20.5%) enterotoxigenic (ETEC), 10 (12.1%) enteroinvasive (EIEC) and seven (8.4%) enterohaemorrhagic (EHEC). The EPEC strains particularly serotype 055, were mostly encountered in children aged over five years. On the other hand, EIEC and ETEC strains were found mainly in adults while EHEC O157: H7 strains occurred in all the age groups studied. This study further stresses the important role of EIEC and ETEC in acute diarrhoeal diseases and the possible implication of EHEC in acute gastroenteritis, especially in children in Lagos, Nigeria.
Asunto(s)
Disentería Bacilar/microbiología , Infecciones por Escherichia coli/microbiología , Escherichia coli/clasificación , Gastroenteritis/microbiología , Infecciones por Salmonella/microbiología , Enfermedad Aguda , Adolescente , Adulto , Distribución por Edad , Niño , Preescolar , Heces/microbiología , Femenino , Humanos , Lactante , Masculino , Persona de Mediana Edad , Nigeria , Serotipificación , Salud UrbanaRESUMEN
A total of 138 children aged between 0-36 months were bled and screened for measles haemagglutination inhibiting (HI)-antibody. Twenty seven children were from age group (0-4) months with 16 (59.3%) seropositive while, 67 and 44 were bled in the group (5-9) and > or = 12 months with 29 (43.3%) and 31 (70.5%) sero positive sera respectively. The distribution of the antibody titre pattern among various age groups suggest vaccination against measles should be at age 9 month. The antibody titres pattern of seroconverted vaccinees also showed that the vaccine administered at our study centre were potent enough to elicit good and protective immune response in vaccinees when given at age 9 month. Our study agrees with the current policy of vaccinating children against measles at age 9 months in Nigeria and should therefore be continued. Based on observations in this study, we suggest; continued administration of the Edmonston-Zagreb strain of measle vaccine currently-in-use in Nigeria, mother's breast-feeding of children for a longer period before the apporpriate age for vaccination, and the possible administration of Vitamin A-a potent immune enhancer, as a supplement during immunization programmes in Nigeria. The introduction of a booster dose of measles vaccine at elementary school age in order to care for the residual unvaccinated children may be a good strategy for measles eradication necessary to be considered in Nigeria and might probably forestall instances of measles outbreaks in children during their second year in school.
Asunto(s)
Anticuerpos Antivirales/análisis , Virus del Sarampión/inmunología , Sarampión/inmunología , Preescolar , Humanos , Lactante , Recién Nacido , Sarampión/prevención & control , Vacuna Antisarampión/administración & dosificación , Nigeria , Factores de TiempoRESUMEN
The potency status and efficacy of measles vaccines were studied in three immunization (EPI) centres in the suburban area of Lagos, Nigeria. A total of 14 vials of measles vaccine were collected and subjected to potency testing while, 203 measles-vaccinated children were recruited for this study. Only 85 (41.87%) of the vaccinees reported back for the post-vaccination follow-up screening. The seroconversion pattern showed that 51(60%) had potent antibody titres ranging from 1:40 to 1:1280, while the remaining 34 (40%) had a low antibody titres between < 1:20 and 1:20. The vaccine potency test showed that only 1 (7.14%) of the 14 vaccine vials collected at these centres had virus titre of 3.5 Log while the remaining 13 (92.86%) had virus titres lower than 3.0 Log: the recommended human dose by the World Health Organisation (WHO) for measles vaccine. The administration of these subpotent and/or impotent vaccines vis-à-vis the status of immune response elicited in the vaccinees may be one of the reasons for the occurrence of measles infection in vaccinated children in the recent time in Nigeria. We herein suggested the subjection of all vaccines to a thorough standard laboratory screening before use in Nigeria.
Asunto(s)
Anticuerpos Antivirales/sangre , Vacuna Antisarampión/inmunología , Vacuna Antisarampión/normas , Virus del Sarampión/inmunología , Centros Comunitarios de Salud , Evaluación de Medicamentos , Evaluación Preclínica de Medicamentos , Estabilidad de Medicamentos , Humanos , Lactante , Vacuna Antisarampión/administración & dosificación , Nigeria , Guías de Práctica Clínica como Asunto , Control de Calidad , Salud Urbana , Organización Mundial de la SaludRESUMEN
Ten Nigerian medicinal plants used traditionally for the treatment of several ailments of both microbial and non-microbial origins were tested on multi-drug resistant S. typhi (MDR) strains of which six of them were active. The results revealed that both the aqueous and ethanol extracts of Terminalia avicennioides, Momordica balsamina, Combretum paniculatum and Trema guineensis were effective on the MDR-S. typhi strains with minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) values ranging from 9.60 to 14 mcg/ml and 24 to 33 mcg/ml, respectively. Whereas, only the aqueous extracts of Morinda lucida and Ocimum gratissimum were found to be active against this pathogen with MIC and MBC values of 9.60 and 24 mcg/ml for M. lucida, 40 and 55 mcg/ml for O. gratissimum, respectively. There was no statistical significant difference (P > 0.05) between the activity of each plant extract and the decoctions prepared from them. All the six active plants showed positive reactions to alkaloids, tannins, flavonoids and anthraquinones but in variable degrees. All but M. balsamina, indicated the presence of saponin.
Asunto(s)
Antibacterianos/farmacología , Medicinas Tradicionales Africanas , Extractos Vegetales/farmacología , Salmonella typhi/efectos de los fármacos , Fiebre Tifoidea/tratamiento farmacológico , Farmacorresistencia Bacteriana , Humanos , Pruebas de Sensibilidad Microbiana , Nigeria , FitoterapiaRESUMEN
OBJECTIVE: The aim of this study was to determine the prevalence of Salmonella enterica serovar typhi in patients with pyrexia of unknown origin (PUO), and antimicrobial resistance in strains isolated from patients with S. typhi in Lagos, Nigeria. STUDY DESIGN: In total, 103 patients were included in this study, subdivided into two categories. Category A comprised 74 patients presenting with PUO, and Category B comprised 29 patients harbouring S. typhi who did not respond to initial treatment. METHODS: Blood samples were cultured for bacterial isolates and identified by standard procedures. Susceptibility testing was performed according to the National Committee for Clinical Laboratory Standards. Plasmid DNA extraction was performed using the alkaline lysis method with Escherichia coli v517 used as the standard. Conjugation and transformation experiments were performed using standard methods. For the latter, E. coli K12 HB 101 (ara-14, galK2, hsd 520, lacyl, leu, mtl-1, Pro A2, rec A13, rps L20, sup E44, thii xyl-5) was used as the recipient and plasmid PBR 322 was used as the positive control. RESULTS: The prevalence of S. typhi in PUO was 16.2% (12/74). In all, 25 of 41 (61.0%) cases were multidrug resistant (MDR) with phenotypic-resistant patterns: ACoCT, ACTCeS, ACTCoCe and ACTS were commonly encountered among the strains. Interestingly, four of the strains harbouring similar plasmid DNA were isolated from patients with hepatosplenomegaly, and a strain harbouring a large transferable plasmid of 81.2MDa was isolated from a psychosis patient. CONCLUSIONS: Our study confirmed the circulation of MDR S. typhi in Lagos, Nigeria. Periodic review of antibiotics used in hospitals is essential as the efficacies of chloramphenicol, ampicillin and cotrimoxazole are now doubtful. Ciprofloxacin and ofloxacin are effective drugs for treatment of typhoid fever, but with current trends of drug abuse in Nigeria, resistance is likely to develop. These results, therefore, provide an early warning signal for the prudent use of fluoroquinolone antimicrobials to preserve their usefulness.
Asunto(s)
Farmacorresistencia Bacteriana Múltiple , Salmonella typhi/aislamiento & purificación , Fiebre Tifoidea/microbiología , Antibacterianos/farmacología , Electroforesis en Gel de Agar , Femenino , Fiebre de Origen Desconocido/epidemiología , Fiebre de Origen Desconocido/microbiología , Humanos , Masculino , Pruebas de Sensibilidad Microbiana , Nigeria/epidemiología , Plásmidos , Salmonella typhi/genética , Fiebre Tifoidea/sangre , Fiebre Tifoidea/epidemiologíaRESUMEN
Sub-Saharan Africa is one of the regions of the globe with the highest measles-related morbidity and mortality. Yet only seven virus isolates from this vast region have been phylogenetically characterized on the basis of their nucleoprotein, the last one in 1991. To characterize the prevalent wild-type viruses and to understand their circulation pattern, a large panel (n = 45) of isolates was collected in Ghana and Nigeria in 1997 and 1998. On the basis of their nucleoprotein sequence, the viruses clearly belong to clade B but a reshuffling of the structure of this clade was proposed, tentatively extending the number of genotypes from two to three on the basis of quantitative criteria. The sequences revealed the co-circulation of at least two distinct viruses in the cities of Lagos and Ibadan, suggesting that the number of susceptible individuals seems to be high enough to support endemic circulation of at least two distinct viruses. The endemic co-circulation of several viruses may well be a characteristic of communities with low vaccination rates. One of these viruses was also found in Accra in 1998 as well as in a 1994 case linked to distant Kenya, suggesting that clade B viruses are prevalent in sub-Saharan Africa while non-B viruses seem to dominate the south of Africa.